Fin Trust Capital Advisors, LLC Intercept Pharmaceuticals, Inc. Transaction History

Fin Trust Capital Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 24, 2023	SELL	$9.99 - $18.71 $4,185 - $7,839	-419 Reduced 25.77%	1,207 $22,000
Q4 2022 Feb 14, 2023	BUY	$11.61 - $16.11 $4,028 - $5,590	347 Added 27.13%	1,626 $20,000
Q3 2022 Oct 20, 2022	SELL	$12.21 - $19.7 $4,993 - $8,057	-409 Reduced 24.23%	1,279 $17,000
Q2 2022 Jul 26, 2022	BUY	$11.23 - $19.59 $3,099 - $5,406	276 Added 19.55%	1,688 $24,000
Q1 2022 May 03, 2022	BUY	$13.37 - $17.79 $4,732 - $6,297	354 Added 33.46%	1,412 $23,000

Q4 2021 Feb 14, 2022	BUY	$14.28 - $19.53 $15,108 - $20,662	1,058 New	1,058 $17,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.